Fenwal Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Fenwal Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0169
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system, aurora plasmapheresis system, blood-pack units with red cell filter, hospital products and blood and plasma center products. It offers products for use in the practice of transfusion medicine, making life-saving blood therapies. Fenwal also provides services such as data management, customer solutions, production management and forecasting tools. The company serves blood centers, hospital blood banks and plasma collection centers. Fenwal is headquartered in Lake Zurich, Illinois, the US.

Fenwal Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fenwal Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fenwal Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Fenwal Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fenwal Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Fenwal Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fenwal Inc, Medical Equipment, Deal Details 10
Partnerships 10
HemaTerra Technologies Enters Into Co-Development Agreement With Fenwal 10
Fenwal Enters Into Co-Marketing Agreement With Applied Science 11
Acquisition 12
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 12
Fenwal Inc – Key Competitors 14
Fenwal Inc – Key Employees 15
Fenwal Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Fenwal Inc, Medical Equipment, Key Facts 2
Fenwal Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Fenwal Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fenwal Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Fenwal Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fenwal Inc, Deals By Market, 2012 to YTD 2018 8
Fenwal Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HemaTerra Technologies Enters Into Co-Development Agreement With Fenwal 10
Fenwal Enters Into Co-Marketing Agreement With Applied Science 11
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 12
Fenwal Inc, Key Competitors 14
Fenwal Inc, Key Employees 15
Fenwal Inc, Subsidiaries 16
Fenwal Inc, Joint Venture 16

List of Figures
Fenwal Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Fenwal Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Fenwal Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Fenwal Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Fenwal Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Fenwal Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Fenwal Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Fenwal Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Fenwal Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Invesco Ltd:戦略・SWOT・企業財務分析
    Invesco Ltd - Strategy, SWOT and Corporate Finance Report Summary Invesco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Seoul City Gas Co Ltd (017390):企業の財務・戦略的SWOT分析
    Seoul City Gas Co Ltd (017390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Vermont Electric Cooperative Inc:企業の戦略的SWOT分析
    Vermont Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Richoux Group Plc:企業の戦略・SWOT・財務情報
    Richoux Group Plc - Strategy, SWOT and Corporate Finance Report Summary Richoux Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hitachi Zosen Corporation (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corporation (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Enmax Corporation-エネルギー分野:企業M&A・提携分析
    Summary ENMAX Corporation (ENMAX), a subsidiary of City of Calgary, is a vertically integrated energy company that generates, transmits and distributes electricity; supplies natural gas; and provides value-added services. Through its subsidiaries, the company undertakes deregulated electricity gener …
  • Alliancebernstein Holding Lp:企業の戦略・SWOT・財務分析
    Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report Summary Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PositiveID Corp (PSID):医療機器:M&Aディール及び事業提携情報
    Summary PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products in …
  • Operation Technology Inc:企業の戦略的SWOT分析
    Operation Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Central Rand Gold Ltd:企業の戦略・SWOT・財務情報
    Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Veolia Environnement SA (VIE)-エネルギー分野:企業M&A・提携分析
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • Sammons Enterprises Inc:戦略・SWOT・企業財務分析
    Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets orphan products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products include dry eye prescription products; dry eye retail products; products for the treatment o …
  • China Resources Pharmaceutical Group Ltd (3320)-製薬・医療分野:企業M&A・提携分析
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …
  • QuadGraphics, Inc. (QUAD):企業の財務・戦略的SWOT分析
    QuadGraphics, Inc. (QUAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Accelovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Accelovance Inc (Accelovance) is a contract research organization that offers CRO services, patient recruitment, and clinical call center services in various therapeutic areas including oncology, immunization/infectious disease, CNS, renal care and others. The organization's CRO services inc …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Response Biomedical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …
  • Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆